This conclusion is further supported by the results that in response to targeted inhibition of the MAPK pathway, TNFα enabled tumor cell survival by inducing c-FLIP upregulation and NF-κB activation.340,341 Therefore, the blockade of TNFα could be a promising synergized therapeutic approach with targeted therapy. The gene discussed is TNF; the disease is neoplasm.